ATRenew (RERE) Research & Development (2020 - 2026)

ATRenew has disclosed Research & Development across 7 years of filings, most recently posting -$10.6 million for Q1 2026.

• Research & Development for Q1 2026 came in at -$10.6 million, down 40.38% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.3 million (down 24.9% YoY), and the FY2025 annual result was $34.9 million, up 221.02% from the prior year.
• Research & Development came in at -$10.6 million for Q1 2026 at ATRenew, down from -$9.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of -$5.4 million in Q3 2023 to a low of -$10.6 million in Q1 2026.
• The 5-year median for Research & Development is -$7.8 million (2024), against an average of -$8.0 million.
• Across the five-year window, Research & Development soared 31.09% in 2023 and plunged 40.8% in 2024, its largest moves.
• ATRenew's Research & Development stood at -$7.9 million in 2022, then declined by 13.77% to -$9.0 million in 2023, then gained by 13.1% to -$7.8 million in 2024, then declined by 14.72% to -$9.0 million in 2025, then dropped by 18.84% to -$10.6 million in 2026.
• The last three Research & Development figures came in at -$10.6 million (Q1 2026), -$9.0 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.